Male-specific W4P/R mutation in the pre-s1 region of hepatitis b virus, increasing the risk of progression of liver diseases in chronic patients

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 3928-3936

  Lee, Seoung Ae ^a   Kim, Ki Jeong ^b   Kim, Dong Won ^a   Kim, Bum Joon ^a  

^a Seoul National University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SEX RATIO; SOUTH KOREA; VIRUS CARRIER; VIRUS MUTATION;

ADULT; AGED; BASE SEQUENCE; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN PRECURSORS; REPUBLIC OF KOREA; RISK ASSESSMENT; SEQUENCE ANALYSIS, DNA; SEX FACTORS;

EID: 84889835661     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01505-13     Document Type: Article

References (40)

1. Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J. Clin. Microbiol. 40:1207-1209.
2. Lavanchy D. 2005. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol. 34(Suppl 1):S1-S3.
3. Chen DS. 1993. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 262:369-370.
4. KCDC. 2007. National health and nutrition survey. Korea Centers for Disease Control and Prevention, Chungcheongbuk-do, South Korea.
5. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S. 2001. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 33:218-223.
6. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ. 2005. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J. Med. Virol. 76:194-202.
7. Kim H, Jee YM, Song BC, Shin JW, Yang SH, Mun HS, Kim HJ, Oh EJ, Yoon JH, Kim YJ, Lee HS, Hwang ES, Cha CY, Kook YH, Kim BJ. 2007. Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea. Intervirology 50: 52-57.
8. Kim HJ, Park JH, Jee Y, Lee SA, Kim H, Song BC, Yang S, Lee M, Yoon JH, Kim YJ, Lee HS, Hwang ES, Kook YH, Kim BJ. 2008. Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. J. Med. Virol. 80:1337-1343.
9. Mun HS, Lee SA, Jee Y, Kim H, Park JH, Song BC, Yoon JH, Kim YJ, Lee HS, Hyun JW, Hwang ES, Kook YH, Kim BJ. 2008. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J. Med. Virol. 80:1189-1194.
10. Lee SA, Mun HS, Kim H, Lee HK, Kim BJ, Hwang ES, Kook YH, Kim BJ. 2011. Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients. J. Med. Virol. 83:65-70.
11. Mun HS, Lee SA, Kim H, Hwang ES, Kook YH, Kim BJ. 2011. Novel F141L preS2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections. J. Virol. 85:123-132.
12. Lee SA, Kim K, Kim H, Kim BJ. 2012. Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases. J. Hepatol. 56:63-69.
13. Kim DW, Lee SA, Hwang ES, Kook YH, Kim BJ. 2012. Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma. PLoS One 7:e47372. doi:10.1371 /journal.pone.0047372.
14. Kim H, Lee SA, Kim DW, Lee SH, Kim BJ. 2013. Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C. PLoS One 8:e54486. doi:10.1371/journal.pone.0054486.
15. Ganem D. 1991. Assembly of hepadnaviral virions and subviral particles. Curr. Top. Microbiol. Immunol. 168:61-83.
16. Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. 1998. Role of the Pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J. Virol. 72:5573-5578.
17. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M. 1986. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc. Natl. Acad. Sci. U. S. A. 83:9174-9178.
18. Wang HC, Huang W, Lai MD, Su IJ. 2006. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 97:683-688.
19. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W. 2004. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023-2032.
20. Caselmann W, Meyer M, Kekulé A, Lauer U, Hofschneider P, Koshy R. 1990. A trans-Activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc. Natl. Acad. Sci. U. S. A. 87:2970-2974.
21. Lok AS, McMahon BJ. 2007. Chronic hepatitis B. Hepatology 45:507-539.
22. McMahon BJ. 2009. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol. Int. 3:334-342.
23. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujimoto I, Inoue A, Yamazaki H, Kawashima T. 1993. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328:1797-1801.
24. Fattovich G, Stroffolini T, Zagni I, Donato F. 2004. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127: S35-S50.
25. Yeh SH, Chen PJ. 2010. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78:172-179.
26. Jepsen P, Vilstrup H, Tarone RE, Friis S, Sorensen HT. 2007. Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends. Int. J. Cancer 121:1624-1626.
27. Ruggieri A, Barbati C, Malorni W. 2010. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int. J. Cancer 127:499-504.
28. El-Serag HB, Rudolph KL. 2007. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576.
29. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. 2009. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 50:1392-1402.
30. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. 2007. Gender disparity in liver cancer due to sex differences in MyD88- dependent IL-6 production. Science 317:121-124.
31. Lay MJ, Wittwer CT. 1997. Real-Time fluorescence genotyping of factor V Leiden during rapid-cycle PCR. Clin. Chem. 43:2262-2267.
32. Selvin PR. 2000. The renaissance of fluorescence resonance energy transfer. Nat. Struct. Biol. 7:730-734.
33. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599.
34. Lee CM, Lu SN, Changchien CS, Yeh CT, Hsu TT, Tang JH, Wang JH, Lin DY, Chen CL, Chen WJ. 1999. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86:1143-1150.
35. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, Tohgo G, Toda N, Ohashi M, Ogura K, Niwa Y, Kawabe T, Omata M. 1995. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 22:1027-1033.
36. Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, Wang J, Wu Y, Liu G, Wu Y, Zhu Y. 1999. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology 30:379-383.
37. Yang WJ, Chang CJ, Yeh SH, Lin WH, Wang SH, Tsai TF, Chen DS, Chen PJ. 2009. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3 kinase pathways. Hepatology 49:1515-1524.
38. Bréchot C. 2004. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127(5 Suppl 1): S56-S61.
39. KNSO. 2007. Annual report on the cause of the death statistics. Korea National Statistical Office, Daejeon, South Korea.
40. Pollicino T, Amaddeo G, Restuccia A, Raffa G, Alibrandi A, Cutroneo G, Favaloro A, Maimone S, Squadrito G, Raimondo G. 2012. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology 56:434-443.